Compare IMNN & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNN | WKSP |
|---|---|---|
| Founded | 1982 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 5.7M |
| IPO Year | 2000 | 2015 |
| Metric | IMNN | WKSP |
|---|---|---|
| Price | $0.54 | $0.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $15.20 | $2.00 |
| AVG Volume (30 Days) | 133.1K | ★ 369.9K |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.89 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $16,101,738.00 |
| Revenue This Year | N/A | $43.01 |
| Revenue Next Year | N/A | $52.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 89.78 |
| 52 Week Low | $0.50 | $0.25 |
| 52 Week High | $4.35 | $3.13 |
| Indicator | IMNN | WKSP |
|---|---|---|
| Relative Strength Index (RSI) | 23.75 | 38.58 |
| Support Level | $0.50 | $0.25 |
| Resistance Level | $1.28 | $0.42 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 9.96 | 18.91 |
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
Worksport Ltd designs, develops, and manufactures products for markets including automotive accessories, consumer electronics, and residential and commercial HVAC systems. The company leverages a growing intellectual property portfolio of patents, designs, and trademarks covering products such as tonneau covers, solar-integrated tonneau covers, portable power stations, hydrogen-based green energy systems, heat pumps, and EV charging solutions. Its segments include soft tonneau covers, consisting mainly of vinyl-wrapped tri-fold and quad-fold covers manufactured by third-party suppliers, and hard tonneau covers, which generate the majority of revenue in the United States and include aluminum tri-fold and quad-fold covers manufactured and assembled in the United States.